-- Robert Preidt
MONDAY, Oct. 7 (HealthDay News) -- Which heart patients
receiving artery-opening stents are at highest risk for heart
attack, stroke or other issues if they undergo a noncardiac surgery
soon after the procedure?
A new study pinpoints two groups at especially elevated risk:
those who underwent the surgery on an emergency basis, and patients
with advanced forms of heart disease.
A stent is a small mesh tube, either of a bare-metal or
drug-coated ("eluting") type, that is inserted into an artery to
help prop it open. Doctors typically urge that patients forgo
nonessential, noncardiac surgeries for at least a year after stent
In the new study, researchers analyzed 2000-2010 data from U.S.
patients who underwent noncardiac surgery -- for example, knee
replacement, respiratory or digestive system surgeries -- within
two years of receiving a stent.
Close to 5 percent of these patients went on to have major heart
problems within a month of their surgery. These problems included
heart attack, death and the need for another procedure to open
The three major risk factors for major heart problems were:
having the surgery on an emergency basis, having had a heart attack
in the six months before the surgery, and having advanced heart
disease, according to a team led by Dr. Mary Hawn, of the
University of Alabama at Birmingham.
The rate of such heart problems was about 5 percent for people
who received bare-metal stents and 4.3 percent for drug-eluting
stents. Drug-eluting stents, which are typically more expensive
than bare-metal versions, emit medicines that help prevent artery
The type of stent received was not associated with major heart
problems occurring more than six months after stent placement.
The study was published Oct. 7 in the
Journal of the American Medical Associationand was to be
presented on Monday at the annual Clinical Congress of the American
College of Surgeons, in Washington, D.C.
Hawn's team noted that about 600,000 stenting procedures are
carried out in the United States each year, and "12 to 23 percent
of these patients [also] undergo noncardiac surgery within two
years of coronary stent placement."
The researchers pointed out that noncardiac surgery after recent
coronary stent placement is associated with increased risk of major
heart problems, but delaying necessary surgery can be a dilemma for
a large number of patients.
"Guidelines recommend delaying noncardiac surgery in patients after coronary stent procedures for one year after drug-eluting stents and for six weeks after bare-metal stents. The evidence underlying these recommendations is limited and conflicting," the study authors wrote.
One heart expert said that decisions around the timing of
noncardiac surgeries for heart patients are complicated, especially
when it comes to the use of anti-clotting drugs.
"Patients getting stents are usually in an age group that has lots of health issues," explained Dr. Kirk Garratt, director of interventional cardiovascular research at Lenox Hill Hospital in New York City. "Some of these people will need surgery in the months that follow a stent. Withholding anti-platelet medicines after six weeks for bare-metal stents, and after six months for drug-eluting stent, is safe," he said.
"The trick is knowing what to do with the ones that need surgery in a shorter period of time," Garratt added. "If a stent is in a key location, like the left main artery, we hospitalize the patient and use IV blood thinners until a few hours before surgery. We turn the blood thinners back on as soon as we can. Some newer drugs, like cangrelor, can be very useful for these patients," he explained.
"It's tricky: we want to offer the benefit of drug-eluting stents when we can, but we can't always identify patients who will need to stop their anti-platelet medicines early," Garratt said. "If we guess wrong, it can be hard-going for some patients."
In an accompanying journal editorial, experts said the findings
may not alter the status quo for many patients.
"The approach for patients with bare-metal stents should not change; these patients usually can undergo surgery within six weeks after coronary stent implantation with very low risk of stent thrombosis," Dr. Emmanouil Brilakis and Dr. Subhash Banerjee of the VA North Texas Health Care System in Dallas wrote.
For patients with drug-eluting stents, surgeries carried out six
months or more after the implantation of the stent appear to have a
very low risk for re-closure of the stent, the editorialists added.
"Hence, nonurgent operations should be postponed until six months
after stent implantation," they said.
The U.S. National Heart, Lung, and Blood Institute has more
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.